Literature DB >> 20623202

Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement--short-term results.

Conor J Magee1, Jonathan Barry, Mayilone Arumugasamy, Shafiq Javed, Robert Macadam, David D Kerrigan.   

Abstract

BACKGROUND: The obesity surgery mortality risk score (OS-MRS) is a five-point scoring system stratifying the risk of post-operative mortality. Patients with a body mass index (BMI) > 60 may also carry an increased risk of peri-operative complications. Laparoscopic sleeve gastrectomy (LSG) as an initial procedure could reduce weight and associated comorbidity allowing a safer, definitive second procedure. We investigated weight loss and risk reduction in patients having LSG as part of a planned two-stage definitive bariatric procedure.
METHODS: Patients with a high OS-MRS (4-5), males with BMI  > 60 or females with BMI  > 65, who underwent LSG were identified from a prospective database. Data were analysed by means of the Mann-Whitney U and Chi-squared test.
RESULTS: Sixty-eight patients underwent LSG. LSG reduced median BMI at 12 months (68 versus 54, P < 0.001) and the OS-MRS (3 versus 2, P = 0.005). An increase in patients considered low risk (OS-MRS, 0-1) was seen following LSG (35% versus 14%, P = 0.006). The proportion of patients with BMI < 50 increased from 0% to 30% (P < 0.001). Improvement or resolution of diabetes and hypertension was seen in 23% and 25% of cases, respectively.
CONCLUSIONS: LSG achieves good weight loss, reduces the OS-MRS and improves obesity-related comorbidity in high-risk surgical patients.

Entities:  

Mesh:

Year:  2011        PMID: 20623202     DOI: 10.1007/s11695-010-0226-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  15 in total

1.  Ghrelin levels and sleeve gastrectomy in super-super-obesity.

Authors:  Régis Cohen; Bernard Uzzan; Hélène Bihan; Inès Khochtali; Gérard Reach; Jean Marc Catheline
Journal:  Obes Surg       Date:  2005 Nov-Dec       Impact factor: 4.129

2.  Primary laparoscopic gastric bypass can be performed safely in patients with BMI >or= 60.

Authors:  Deborah Abeles; Julie J Kim; Michael E Tarnoff; Sajani Shah; Scott A Shikora
Journal:  J Am Coll Surg       Date:  2008-12-18       Impact factor: 6.113

3.  Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass.

Authors:  D S Tichansky; E J DeMaria; A Z Fernandez; J M Kellum; L G Wolfe; J G Meador; H J Sugerman
Journal:  Surg Endosc       Date:  2005-05-05       Impact factor: 4.584

4.  Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass.

Authors:  Eric J DeMaria; Dana Portenier; Luke Wolfe
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

5.  Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study.

Authors:  J Karlsson; C Taft; A Rydén; L Sjöström; M Sullivan
Journal:  Int J Obes (Lond)       Date:  2007-03-13       Impact factor: 5.095

6.  Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50).

Authors:  Luca Milone; Vivian Strong; Michel Gagner
Journal:  Obes Surg       Date:  2005-05       Impact factor: 4.129

7.  Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients.

Authors:  Philippe Mognol; Denis Chosidow; Jean-Pierre Marmuse
Journal:  Obes Surg       Date:  2005-08       Impact factor: 4.129

8.  Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels.

Authors:  F B Langer; M A Reza Hoda; A Bohdjalian; F X Felberbauer; J Zacherl; E Wenzl; K Schindler; A Luger; B Ludvik; G Prager
Journal:  Obes Surg       Date:  2005-08       Impact factor: 4.129

9.  Longitudinal gastrectomy as a treatment for the high-risk super-obese patient.

Authors:  Gidon Almogy; Peter F Crookes; Gary J Anthone
Journal:  Obes Surg       Date:  2004-04       Impact factor: 4.129

10.  Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients.

Authors:  Alexandra Dresel; Joseph A Kuhn; Todd M McCarty
Journal:  Am J Surg       Date:  2004-02       Impact factor: 2.565

View more
  16 in total

1.  Effect of sleeve gastrectomy on osteopontin circulating levels and expression in adipose tissue and liver in rats.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

2.  Functional importance of laparoscopic sleeve gastrectomy for the lower esophageal sphincter in patients with morbid obesity.

Authors:  Wiebke V Petersen; Tobias Meile; Markus A Küper; Marty Zdichavsky; Alfred Königsrainer; Joachim H Schneider
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

3.  Results of Laparoscopic Sleeve Gastrectomy-5-Year Follow-Up Study in an Eastern European Emerging Bariatric Center.

Authors:  Radu Mircea Neagoe; Mircea Mureșan; Șerban Bancu; Ionuț Balmos; Vasile Băișan; Septimiu Voidăzan; Daniela Sala
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

Review 4.  The impact of obesity surgery on musculoskeletal disease.

Authors:  Ussamah El-Khani; Ahmed Ahmed; Sherif Hakky; Jean Nehme; Jonathan Cousins; Harvinder Chahal; Sanjay Purkayastha
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

Review 5.  Impact of gastrointestinal surgery on cardiometabolic risk.

Authors:  Fady Moustarah; Audrée Gilbert; Jean-Pierre Després; André Tchernof
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

6.  Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy.

Authors:  Ximena Terra; Teresa Auguet; Esther Guiu-Jurado; Alba Berlanga; Josep Maria Orellana-Gavaldà; Mercè Hernández; Fàtima Sabench; Jose Antonio Porras; Jordi Llutart; Salomé Martinez; Carmen Aguilar; Daniel Del Castillo; Cristóbal Richart
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

7.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

8.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

9.  Hematological, Biochemical, and Immunological Laboratory and Histomorphological Effects of Sleeve Gastrectomy on Female Rats.

Authors:  Ali Aktekin; Kazım Kazan; Pembegul Gunes; Murat Yekrek; Tolga Muftuoglu; Abdullah Saglam
Journal:  Indian J Surg       Date:  2013-05-05       Impact factor: 0.656

10.  Weight loss outcomes and complications from bariatric surgery in the super super obese.

Authors:  Oscar K Serrano; Jonathan E Tannebaum; Lindsay Cumella; Jenny Choi; Pratibha Vemulapalli; W Scott Melvin; Diego R Camacho
Journal:  Surg Endosc       Date:  2015-08-25       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.